US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Monash IVF Group Limited (MVF) 銘柄情報

Monash IVF Group Limited (MVF)

0.705

-0.01

(-1.40%)

終了 7月3日 3:00PM

Monash IVF Group Limited (MVF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.705

( -1.40% )

買値

0.705

売値

0.71

出来高

465,596

0.705 日の範囲 0.725

0.575 52 週間の範囲 0.895

時価総額

前日終値

0.715

始値

0.715

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 690,229

発行済株式数

389,634,840

配当利回り

0.01 (7.32%)

PER

18.27

1 株当たり利益 (EPS)

0.04

歳入

269.39M

純利益

15.16M

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatme... Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.monashivfgroup.com.au

本社

Richmond, Australia

設立

2026

Monash IVF Group Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker MVF. The last closing price for Monash IVF was AUD0.72. Over the last year, Monash IVF shares have traded in a share price range of AUD 0.575 to AUD 0.895.

Monash IVF currently has 389,634,840 shares in issue. The market capitalisation of Monash IVF is AUD274.69 million. Monash IVF has a price to earnings ratio (PE ratio) of 18.27.

Is it time to buy Monash IVF Group Ltd following its latest acquisition?

http://www.fool.com.au/2015/03/12/is-it-time-to-buy-monash-ivf-group-ltd-following-its-latest-acquisition/

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.005	-0.704225352113	0.71	0.735	0.705	882442	0.71950972	DE
4	-0.0075	-1.05263157895	0.7125	0.735	0.625	855561	0.70769558	DE
12	0.035	5.22388059701	0.67	0.8	0.625	733987	0.72880503	DE
26	-0.025	-3.42465753425	0.73	0.8	0.61	712451	0.71464961	DE
52	-0.025	-3.42465753425	0.73	0.895	0.575	1687313	0.73928688	DE
156	-0.44	-38.4279475983	1.145	1.53	0.5375	1372258	0.88749143	DE
260	-0.15	-17.5438596491	0.855	1.53	0.5375	1109867	0.92482139	DE

MVF - Frequently Asked Questions (FAQ)

What is the current Monash IVF Group Limited share price?

The current share price of Monash IVF Group Limited is AUD 0.705

How many Monash IVF Group Limited shares are in issue?

Monash IVF Group Limited has 389,634,840 shares in issue

What is the market cap of Monash IVF Group Limited?

The market capitalisation of Monash IVF Group Limited is AUD 274.69M

What is the 1 year trading range for Monash IVF Group Limited share price?

Monash IVF Group Limited has traded in the range of AUD 0.575 to AUD 0.895 during the past year

What is the PE ratio of Monash IVF Group Limited?

The price to earnings ratio of Monash IVF Group Limited is 18.27

What is the cash to sales ratio of Monash IVF Group Limited?

The cash to sales ratio of Monash IVF Group Limited is 1.03

What is the registered address of Monash IVF Group Limited?

The registered address for Monash IVF Group Limited is Pelaco Building 1, Richmond, Victoria, 3121

What is the Monash IVF Group Limited website address?

The website address for Monash IVF Group Limited is www.monashivfgroup.com.au

Which industry sector does Monash IVF Group Limited operate in?

Monash IVF Group Limited operates in the Medical Diagnostics & Screening sector

bubba412

bubba412 4分前

If you have 500,000 shares and just want a dollar a share you’ll have 500,000 dollars If you get a 15 to 1 split you wind up with 33,333 shares at 4.00 you have what we have now If it does to 10.00 like he said you have 330 thousand dollars Much less than it going to a dollar now

scoobey-do

scoobey-do 6分前

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

Roadmap Highlights Multiple AI-Driven Growth Initiatives Designed to Expand the Company's Technology Platform and Long-Term Market Opportunity

TORONTO, ON

scoobey-do

scoobey-do 6分前

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

Roadmap Highlights Multiple AI-Driven Growth Initiatives Designed to Expand the Company's Technology Platform and Long-Term Market Opportunity

TORONTO, ON

againstallodds

againstallodds 7分前

Lazerson sure ecstatic to read that !

https://investorshub.advfn.com/uimage/uploads/2026/7/3/imefuIMG_0494.jpeg

Truthsocial

Truthsocial 7分前

HIGH CHANCE OF APPROVAL....imo
Listen to the regulatory experts not fudsters.....

The chances for Vivos Inc (RDGL) to receive approval for its Early Feasibility Study (EFS) Investigational Device Exemption (IDE) are considered highly favorable by investors and regulatory exper

Just give me $1.50

Just give me $1.50 10分前

Why was my account suspended for one week?

Thanks.

manibiotech

manibiotech 11分前

Anyone has access to what was presented ?

pdicamillo1

pdicamillo1 12分前

It certainly looks like the writeup created some volume and upward price momentum. Can you let us know when specifically that writeup was published and share what was written? Was is published as one of the main companies that MicroCap Club profiles or just simply shared with members from the foru

cabos_tacos

cabos_tacos 14分前

Waukeenah is just a few miles east of our home.. Sometimes we park across the highway where the Trulieve grow facility ( its huge) and when the winds are right.. roll down the windows and? After a few minutes, you're high and that pizza you brought tastes so good . hahaha

Goats'nCrows

Goats'nCrows 15分前

I can't speak to small pharma but Copy Review is a time consumer at BP and ultimately expensive. That makes me believe (that while I love your idea), that the company would pass.

(My personal speculation has always been that the CR process and its costs is why we have no much neede

PutzMueler

PutzMueler 20分前

ge11 I can’t get in and look at the full report, is it for the air permit? It does state click on air permit, but I thought once construction was started we did not need to apply again.

Also is DWEE the new NDEE for air permitting,

Or is this part of an ESIA applicat

jammy32

jammy32 20分前

If all of this is really happening, isn’t Nasrat accountable? He’s the CEO and he’s doing nothing to protect the PPS. 82 cents to 34 cents in 12 months and he laughs it off with his bs comments about the better we do the worse the stock does. Also, the 5 million really pisses me off

LocWolf

LocWolf 20分前

Chazzy and Alan...thank you.eom

OldAIMGuy

OldAIMGuy 20分前

Report on my Portfolios....................

My Twinvest IRA that I converted to AIM.....
https://investorshub.advfn.com/uimage/uploads/2026/7/3/klgtdSimpIRA.jpg
The VUG Growth fund stalled for June and so did the portfolio.

Business Sector ETFs (each manag

deri21

deri21 22分前

Nano / Micro / Small Cap Press Flashback 6/29 - 7/3

$SSII SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
https://www.globenewswire.com/news-release/2026/06/30/3319802/0/en/SS-Innovations-Named-Outstanding-Company-Winner-at-the-202

deri21

deri21 22分前

Nano / Micro / Small Cap Press Flashback 6/29 - 7/3

$SSII SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
https://www.globenewswire.com/news-release/2026/06/30/3319802/0/en/SS-Innovations-Named-Outstanding-Company-Winner-at-the-202

Wehalls

Wehalls 23分前

He is saying that current technology has made the patent obsolete and it doesn't reflect how he is currently doing business.

nowwhat2

nowwhat2 23分前

https://www.youtube.com/shorts/kkEdi9LJ-mY
.

al507

and more Tx date: 2026-07-02
Filed: 2026-07-03 03:06

Neumeyer, Keith
4 - Director of Issuer
Common Shares
10 - Acquisition or disposition in the public market
$170,000
+250,000 vol
$0.6800 each
Direct Ownership
47,092,813

ARbigguy1

ARbigguy1 24分前

tombe, great question, the only answer as why is that there has been huge naked shorting going on all the way back to when ELTP moved to the OTC. Illegal short sellers love the OTC market because the SEC basically ignores all the rampant fraud on the OTC whether it is the fake companies or market m

MightyX

MightyX 27分前

Evidently shorts have until Aug 5 to fully cover.

SeaBlue

SeaBlue 28分前

A bit of a strange interview. In a way, he seemed to be dialing back expectations/excitement a bit.

trunkmonk

trunkmonk 30分前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/akghwXAGUSD_2026-07-03_07-32-42.png

HoldHigh

HoldHigh 30分前

Everything good here. Staying alert for developments on rescheduling, Safe Banking etc. I'm looking forward to the end of the rescheduling hearing on 15 July. While it will have limited impact on TRLV, it will have some impact if approved. Meanwhile the https://investors.trulieve.com/2026-07-01-Trul

Euronext Invest In Franc...

Invesco BulletShares 202...

Bank Hapoalim BM (PK)

CANN IS Capital

Nippon Television

GFT Technologies

Orbia Advance Corp S A B... (PK)

DJ Global Emerging Marke...

Australian Strategic Mat...

Insurance Australia

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。